April 19, 2024
Celltrion’s Herzuma obtains final approval from USFDA
[DISCLOSURE] Celltrion (068270) announced on Dec. 17 that its Herzuma, a biosimilar of Roche’s Herceptin, has been granted final approval for sales from US Food and Drug Administrations.
By Hwang You-mee (glamazon@heraldcorp.com)
EDITOR'S PICKS
-
S-Oil donates W560m to support firefighters
-
LG CNS teams up with Yonsei University to nurture AI specialists
-
Polestar 4 to make Korean debut in June
-
S. Korea pledges W23tr venture capital fund for green investment at G20 meeting
-
Sungsimdang outperforms bakery giants to log sales over W100b
-
France rejects opening Paris flight routes to T'way Air, deals blow to Korean Air merger
-
SK hynix chief underscores chip cooperation between Korea, US
-
Trilateral talks acknowledge ‘serious’ slumps of won, yen
